Its subsidiary, Kolon Industries, saw both sales and operating profit rise year-on-year, driven by the success of its operational efficiency (OE) projects and strong sales growth in the industrial materials and chemicals sectors.
Kolon Global, another subsidiary, experienced a slight decline in sales compared to the previous year, but significantly increased its operating profit due to enhanced site management and improved cost ratios. Kolon Mobility Group also reported growth in both sales and operating profit, benefiting from strong sales of premium imported vehicles. The net loss was attributed to increased valuation losses related to convertible bonds due to the rise in Kolon TissueGene's stock price.
Kolon Industries' manufacturing division is expected to continue its profitability-focused growth, supported by ongoing operational efficiency efforts and an increased share of high-value products. Kolon Global recorded new orders worth 404.4 billion won in the first quarter, marking a 19% increase from the same period last year.
Meanwhile, Kolon Industries is concentrating on strengthening its competitiveness through initiatives centered around its research and development (R&D) hub, the Kolon One&Only Tower. These initiatives include reorganizing the R&D team, expanding AI-based R&D processes, and enhancing its intellectual property portfolio.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.